Picard Medical prices $5 million follow-on offering at $0.30 per share unit
Picard Medical
Picard Medical PMI | 0.00 |
- Picard Medical priced registered follow-on offering raising about USD 5 million in gross proceeds.
- Deal sold 16,666,667 common shares or pre-funded warrants, each paired with Series A warrants and Series B warrants, at USD 0.3 per share-and-warrants package.
- Common warrants carry USD 0.35 exercise price; Series A warrants run 5 years; Series B warrants run 24 months; pre-funded warrants are exercisable at USD 0.0001 with no expiration until fully exercised.
- Offering closed May 6, 2026; proceeds earmarked for working capital, general corporate purposes, debt repayment.
- WestPark Capital served as sole placement agent; fees set at 7% of gross proceeds, financial advisor management fee set at 1%.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Picard Medical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001829126-26-004960), on May 11, 2026, and is solely responsible for the information contained therein.
